Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands †
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Structure‐Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands † ; volume:8 ; number:3 ; year:2019 ; pages:285-297 ; extent:13
ChemistryOpen ; 8, Heft 3 (2019), 285-297 (gesamt 13)
- Urheber
-
Pockes, Steffen
Wifling, David
Buschauer, Armin
Elz, Sigurd
- DOI
-
10.1002/open.201900011
- URN
-
urn:nbn:de:101:1-2022072806554223357302
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pockes, Steffen
- Wifling, David
- Buschauer, Armin
- Elz, Sigurd
Ähnliche Objekte (12)
Highly potent and selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships of mono- and bivalent ligands
Synthesis and structure-activity relationships of NG-acylated arylalkylguanidines and related compounds as histamine receptor ligands : searching for selective H4R agonists
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
Hetarylalkyl(aryl)cyanoguanidines as histamine H4 receptor ligands : synthesis, chiral separation, pharmacological characterization, structure-activity and -selectivity relationships
Hetarylalkyl(aryl)cyanoguanidines as histamine H4 receptor ligands: Synthesis, chiral separation, pharmacological characterization, structure-activity and -selectivity relationships
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Structure‐Activity Relationship Studies of Hydantoin‐Cored Ligands for Smoothened Receptor
Histamine intolerance : histamine and seasickness
Syntheses and evaluation of novel histamine H3 receptor ligands and multi-target-directed ligands as neuroprotective agents
Structure-activity relationship analysis of the subtype-selective Sirt5 inhibitor balsalazide
Synthesis and pharmacological characterization of new tetrahydrofuran based compounds as histamine receptor ligands
Molecular pharmacology of histamine H3 receptor ligands and their implications in neurogenetic disorders
Highly potent and selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships of mono- and bivalent ligands
Synthesis and structure-activity relationships of NG-acylated arylalkylguanidines and related compounds as histamine receptor ligands : searching for selective H4R agonists
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
Hetarylalkyl(aryl)cyanoguanidines as histamine H4 receptor ligands : synthesis, chiral separation, pharmacological characterization, structure-activity and -selectivity relationships
Hetarylalkyl(aryl)cyanoguanidines as histamine H4 receptor ligands: Synthesis, chiral separation, pharmacological characterization, structure-activity and -selectivity relationships
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Structure‐Activity Relationship Studies of Hydantoin‐Cored Ligands for Smoothened Receptor
Histamine intolerance : histamine and seasickness
Syntheses and evaluation of novel histamine H3 receptor ligands and multi-target-directed ligands as neuroprotective agents
Structure-activity relationship analysis of the subtype-selective Sirt5 inhibitor balsalazide
Synthesis and pharmacological characterization of new tetrahydrofuran based compounds as histamine receptor ligands
Molecular pharmacology of histamine H3 receptor ligands and their implications in neurogenetic disorders
Highly potent and selective acylguanidine-type histamine H2 receptor agonists: synthesis and structure-activity relationships of mono- and bivalent ligands
Synthesis and structure-activity relationships of NG-acylated arylalkylguanidines and related compounds as histamine receptor ligands : searching for selective H4R agonists
Highly potent, selective acylguanidine type histamine H2-receptor agonists : synthesis and structure-activity relationships
Hetarylalkyl(aryl)cyanoguanidines as histamine H4 receptor ligands : synthesis, chiral separation, pharmacological characterization, structure-activity and -selectivity relationships
Hetarylalkyl(aryl)cyanoguanidines as histamine H4 receptor ligands: Synthesis, chiral separation, pharmacological characterization, structure-activity and -selectivity relationships
Synthesis and Pharmacological Characterization of Subtype-Selective Ligands, Including Radio- and Fluorescence Labeled Ligands, for the Histamine H₂ Receptor
Structure‐Activity Relationship Studies of Hydantoin‐Cored Ligands for Smoothened Receptor
Histamine intolerance : histamine and seasickness
Syntheses and evaluation of novel histamine H3 receptor ligands and multi-target-directed ligands as neuroprotective agents
Structure-activity relationship analysis of the subtype-selective Sirt5 inhibitor balsalazide
Synthesis and pharmacological characterization of new tetrahydrofuran based compounds as histamine receptor ligands